Wealth Enhancement Advisory Services LLC Acquires 844 Shares of Oscar Health, Inc. (NYSE:OSCR)

Wealth Enhancement Advisory Services LLC increased its holdings in Oscar Health, Inc. (NYSE:OSCR) by 7.5% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 12,028 shares of the company’s stock after purchasing an additional 844 shares during the period. Wealth Enhancement Advisory Services LLC’s holdings in Oscar Health were worth $255,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of OSCR. Toth Financial Advisory Corp boosted its holdings in Oscar Health by 73,185.7% during the third quarter. Toth Financial Advisory Corp now owns 51,300 shares of the company’s stock valued at $1,088,000 after acquiring an additional 51,230 shares during the period. Allspring Global Investments Holdings LLC boosted its holdings in Oscar Health by 1.7% during the third quarter. Allspring Global Investments Holdings LLC now owns 109,074 shares of the company’s stock valued at $2,313,000 after acquiring an additional 1,866 shares during the period. Optimum Investment Advisors bought a new stake in Oscar Health during the third quarter valued at about $142,000. nVerses Capital LLC boosted its holdings in Oscar Health by 36.1% during the third quarter. nVerses Capital LLC now owns 18,100 shares of the company’s stock valued at $384,000 after acquiring an additional 4,800 shares during the period. Finally, Creative Planning boosted its holdings in Oscar Health by 73.8% during the third quarter. Creative Planning now owns 31,296 shares of the company’s stock valued at $664,000 after acquiring an additional 13,286 shares during the period. 75.70% of the stock is currently owned by institutional investors.

Oscar Health Stock Performance

NYSE:OSCR opened at $13.80 on Tuesday. Oscar Health, Inc. has a 12-month low of $6.80 and a 12-month high of $23.79. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.26. The firm has a market capitalization of $3.34 billion, a PE ratio of -230.00, a price-to-earnings-growth ratio of 31.17 and a beta of 1.67. The firm has a 50-day moving average price of $18.45 and a 200 day moving average price of $18.36.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings results on Thursday, November 7th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.20) by ($0.02). Oscar Health had a return on equity of 2.91% and a net margin of 0.35%. The business had revenue of $2.42 billion during the quarter, compared to analyst estimates of $2.33 billion. During the same period last year, the company earned ($0.29) EPS. The business’s revenue for the quarter was up 68.3% on a year-over-year basis. Research analysts anticipate that Oscar Health, Inc. will post 0.02 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of equities research analysts have issued reports on OSCR shares. Bank of America cut shares of Oscar Health from a “neutral” rating to an “underperform” rating and decreased their price target for the company from $21.00 to $13.50 in a report on Wednesday, November 6th. UBS Group assumed coverage on shares of Oscar Health in a research report on Monday, October 7th. They set a “neutral” rating and a $23.00 price objective for the company. Finally, Piper Sandler reaffirmed an “overweight” rating and set a $28.00 price objective on shares of Oscar Health in a research report on Tuesday, September 10th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, four have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, Oscar Health has an average rating of “Moderate Buy” and a consensus price target of $22.93.

Insider Buying and Selling

In related news, EVP Alessandrea C. Quane sold 16,793 shares of the stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $17.06, for a total value of $286,488.58. Following the completion of the transaction, the executive vice president now owns 392,607 shares of the company’s stock, valued at $6,697,875.42. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. In other Oscar Health news, EVP Alessandrea C. Quane sold 16,793 shares of the company’s stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $17.06, for a total transaction of $286,488.58. Following the sale, the executive vice president now directly owns 392,607 shares of the company’s stock, valued at approximately $6,697,875.42. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Mario Schlosser sold 3,198 shares of the company’s stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total transaction of $57,532.02. Following the sale, the insider now directly owns 76,982 shares in the company, valued at $1,384,906.18. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 169,569 shares of company stock valued at $3,007,069 over the last quarter. Corporate insiders own 25.11% of the company’s stock.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.